Mutation analysis of patients with neurodegenerative disorders using NeuroX array

Mahdi Ghani1, Anthony E Lang2, Lorne Zinman3

  • 1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.

Neurobiology of Aging
|September 2, 2014
PubMed
Summary

The NeuroX array enables rapid genetic screening for neurodegenerative diseases, identifying causative mutations in Alzheimer's and ALS patients. This cost-effective tool aids in diagnosing rare damaging variants, improving mutation analysis efficiency.

Related Concept Videos